AstraZeneca Can't Boost a Cancer Drug Stockpile for Brexit

(Bloomberg) -- AstraZeneca Plc is adding to its drug stockpile to ensure supplies for patients after Brexit -- but there’s a worrisome exception.

Bloomberg Quint

Add BloombergQuint App to Home screen.